Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - August 2014


4th Annual MARKET & PATIENT ACCESS in LATIN AMERICA

19 Aug 2014 - 20 Aug 2014 - Rio de Janiero, Brazil



Bookmark and Share


This two-day event will allow all participants the ability to learn about the current market access approaches which are required for each market in order for them to have greater certainty that their products will be able to deliver real value in the correct terms (cost-effectiveness/ cost-utility/ cost-benefit/ cost-minimization). Participants will hear from a range of Payers (Public & Private), HTAs and academics who are all shaping the market access landscape in Latin America and will hear first-hand how the requirements for market access are evolving and what will need to be done to maximize chances of a commercially successful product launch. 2 EVENTS IN ONE: 1. Latin American Payers & HTA Forum 2. Market & Patient Access in Latin America All participants will leave the event with the most up to date information based on expert opinion as to which market access approaches will offer the highest likelihood of success for their products and will also be able to meet, interact and engage with senior-level decision makers from across this vital region. Request agenda at http://www.nextlevelpharma.com/events/request_agenda/4th_annual_pharmaceutical_medical_device_market_patient_access_in_latin_america

Further information
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!